AMANDA TUTTLE: Open Payments
NPI 1932665221 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$372 in 16 payments from 7 companies in 2025. Trend: 2023 $496 · 2024 $491 · 2025 $372
Food & beverage: $273Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $162 |
| MILLICENT US INC | 3 | $52 |
| Organon LLC | 2 | $46 |
| SHIELD THERAPEUTICS INC | 2 | $37 |
| Hologic Sales and Service, LLC | 1 | $30 |
| Sumitomo Pharma America, Inc. | 2 | $29 |
| PFIZER INC. | 1 | $17 |
Products named: Veozah, NEXPLANON, ACCRUFER, INTRAROSA, NOVASURE, MYFEMBREE, FEMRING, ABRYSVO.
Industry payments across AL — which companies pay providers there.
